Although the pathologic consequences of C. trachomatis genital infection are well-established, the mechanism(s) that result in chlamydia-induced tissue damage are not fully understood. We have reviewed in vitro, animal, and human data related to the pathogenesis of chlamydial disease in an effort to better understand how reproductive sequelae result from C. trachomatis infection. Abundant in vitro data suggest the inflammatory response to chlamydiae is initiated and sustained by actively infected non-immune host epithelial cells. The mouse model indicates a critical role for chlamydia-activation of the innate immune receptor, toll-like receptor 2 (TLR2), and subsequent inflammatory cell influx and activation which contributes to the development of chronic genital tract tissue damage. Data from recent vaccine studies in the murine model and from human immunoepidemiologic studies support a role for chlamydia-specific CD4 Th1-IFN-γ-producing cells in protection from infection and disease. However, limited evidence obtained using animal models of repeated infection indicates that while the adaptive T cell response is a key mechanism involved in controlling or eliminating infection, it may have a double-edged nature, and contribute to tissue damage. Important immunologic questions include whether anamnestic CD4 T cell responses drive disease rather than protect against disease, and the role of specific immune cells and inflammatory mediators in the induction of tissue damage with primary and repeated infections. Continued study of the complex molecular and cellular interactions between chlamydiae and their host, and large-scale prospective immunoepidemiologic and immunopathologic studies are needed to address gaps in our understanding of pathogenesis, which thwart development of optimally effective control programs including vaccine development.
Introduction
Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern because of their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease (PID), infertility and ectopic pregnancy. Although the pathologic consequences of infection are well-established, the mechanism(s) of chlamydiainduced tissue damage are not fully understood. Histological examination of tissues from women with PID caused by C. trachomatis reveals neutrophils in endometrial surface epithelium and within gland lumens, dense subepithelial stromal lymphocytic infiltration, stromal plasma cells, and germinal centers containing transformed lymphocytes 1 . The prominence of both neutrophils and chronic inflammatory cells in infected human female genital tract tissues does not assist in the determination of specific responses responsible for disease sequelae.
Due to the inherent difficulties in acquiring human tissues for study, researchers have taken advantage of multiple animal models of chlamydial infection to examine the nature and timing of the inflammatory response that occurs in the female genital tract after in vivo infection. Mouse and guinea pig models show that the response to primary chlamydial infection occurs within 1 to 2 days of infection and is characterized by mucosal infiltration with neutrophils and modest numbers of monocytes [2] [3] [4] [5] . Neutrophils are recruited in large numbers to the site of infection and are capable of killing accessible elementary bodies (EBs). Later, T cells accumulate at the site of chlamydial infection and play a critical role in controlling the infection [6] [7] [8] . A consistent observation in the murine model is that tubal dilatation is a frequent end result of primary infection. Thus, the inflammatory process resulting from a single chlamydial insult may be sufficient to induce tubal damage and infertility. In contrast, in female guinea pigs, the host response to primary infection results in long-term tissue damage in a minority of infected animals 5, 9 . Analogous information on the proportion of women developing tubal damage following chlamydial infection is not available, but most infected women do not appear to develop clinical complications 10, 11 . Considering reported complication rates together with the high prevalence of genital tract C. trachomatis infection in women 12 , it appears that the guinea pig model may more closely approximate human disease. In female animals and women, the multi-dimensional set of immune events that occurs upon infection ultimately results in an acquired immune response. Unfortunately, the adaptive response induced by infection is not effective in preventing reinfection, and the host's oviducts remain vulnerable to repeated inflammatory insult.
The cellular paradigm of chlamydia pathogenesis 13 states that the host response to chlamydiae is initiated and sustained by epithelial cells that are the primary targets of chlamydial infection. Infected host epithelial cells act as first responders, initiating and propagating immune responses. They secrete chemokines that recruit inflammatory leukocytes to the site of infection, as well as cytokines that induce and augment the cellular inflammatory response 14 and these mediators induce direct damage to the tissues. Upon reinfection, host cell release of chemokines leads to recruitment of chlamydia-specific immune cells that rapidly amplify the response. The release of proteases, clotting factors and tissue growth factors from infected host cells and infiltrating inflammatory cells leads to tissue damage and eventual scarring-the hallmark of chlamydia-induced oviduct disease. The cellular paradigm makes no distinction between damage induced by professional innate immune cells (neutrophils and monocytes) and adaptive lymphocyte populations, but assumes that both cell populations contribute to pathogenesis. Chronic chlamydial infections are common 16 and would lead to ongoing release of mediators that promote continued influx of inflammatory cells, damage to host epithelium, scarring and ultimately, fibrosis and scarring. Since reinfection with chlamydiae is a frequent occurrence 15 , repeated inflammatory responses may lead to repeated insult to the tissues, and promote tissue scarring.
Studies using the murine model of C. trachomatis genital tract infection have established that resolution of genital chlamydial infection is dependent upon an influx of IFNγ-producing CD4+ Th1 cells 8, [17] [18] [19] [20] . The immunological paradigm for pathogenesis is based on the premise that T cell responses that are essential to host defense may also cause collateral tissue damage 21 . It was speculated that host T cell responses induced upon primary infection to a species-specific antigen were increased with subsequent infections, promoting tissue damage and scarring 22 . Chlamydia heat shock protein 60 (Chsp60) has been investigated as a potential antigen responsible for induction of delayed type hypersensitivity (DTH)-induced disease. This molecule attracted attention as a candidate "pathogenic" antigen after studies in immune guinea pigs and monkeys suggested direct eye inoculation with this "sensitizing" antigen promoted heightened inflammation of the conjunctiva 23, 24 . However, residual Triton-X detergent contaminating the extracts proved to be the inducer of disease. Later studies conducted in the guinea pig model of trachoma revealed a protective role for vaccination with Chsp60 25 , and although human studies have revealed detection of elevated titers of antibody to Hsp60 in those with more severe disease 26, 27 , this may simply reflect increased exposure to chlamydia through chronic or repeated infection. A recent large prospective study of women with PID did not reveal a correlation of increased antibody titers to Chsp60 with worse outcome 28 . Furthermore, IFNγ production by peripheral blood T cells stimulated with Chsp60 predicts protection from incident infection in women at high risk for repeated infection 29 .
Despite the lack of evidence for a specific chlamydial "pathogenic" antigen that primes anamnestic T cell responses, in the presence of chronic or repeated infection, an ongoing or augmented memory T cell response might heighten disease development. Monkey 30 and guinea pig 31 models of repeated infection indicate that CD4 and CD8 T cells infiltrate more rapidly and in larger numbers than neutrophils during repeat oviduct infections, and this recurrent inflammatory reaction ultimately culminates in fibrosis and scarring. Importantly, because guinea pigs develop sufficient immunity after primary infection to significantly limit bacterial burden during a secondary vaginal infection, this indicates that very small amounts of chlamydiae may be sufficient to induce an enhanced T cell response in the oviduct that culminates in disease. Although CD4 and CD8 T cells have been observed in both of these models of repeated infection, with CD8 T cells being predominant in the monkey model, no data exist on the specific role of CD8 T cells in pathogenesis in humans.
Because the ultimate goal of chlamydia control programs is to prevent reproductive tract complications, a more complete understanding of how C. trachomatis infection leads to sequelae is needed. The cellular paradigm of pathogenesis does not invoke professional innate or adaptive immune cells as being more or less responsible for disease development. Instead, the central player of pathogenesis is assumed to be the host epithelial cell which drives the inflammatory response through its recognition of chlamydia infection. Epithelial cells possess surface and intracellular innate immune receptors that enable them to recognize conserved chlamydial ligands, and initiate inflammation. Thus, the infected epithelial cell serves as a key innate responder cell. It follows that a determination of genetic polymorphisms that result in heightened innate inflammatory responses to chlamydia may serve to identify persons at high risk for disease development and in need of increased levels of screening and treatment. Furthermore, since tissue damaging responses begin as soon as the bacterium infects the oviduct epithelium, and the infected epithelial cells will continue to drive inflammation as long as the pathogen remains, control programs should seek to provide treatment before infection of the oviduct occurs or to shorten the duration of oviduct infection as much as possible.
The long-term morbidities of chlamydial infection primarily result from tissue damage at the level of the oviduct. The cellular paradigm imposes a prerequisite for infection of the oviduct to occur for disease to develop. Thus, an adaptive immune response (induced by infection at the cervix or by vaccination) that prevents ascension of bacteria to the oviduct, upon initial or repeated infection, would effectively prevent disease. This has important implications for the design of screening and vaccine control programs for women since it indicates that infection of the cervix does not correlate with risk of disease as long as a strong adaptive immune response is documented in the same patient. It follows that a vaccine that induces responses potent enough to prevent oviduct infection while containing infection to the cervix might also be effective in preventing disease sequelae. A determination of responses that predict protection from reinfection in those at high risk due to exposure is a realistic goal. If these responses could be demonstrated to be the same as those that protect an individual from infection of the upper genital tract, then these responses could be used as markers of women at low-risk for infection and disease. Those without such markers would be considered as high-risk, and in need of an increased frequency of screening. Since ample data indicate chlamydia-specific CD4 Th1-IFN-γ-producing cells are key mediators of host defense; a goal for vaccine development would be to determine chlamydia antigens and adjuvants that induce a strong CD4 Th1 memory response. Importantly, the induction of sterilizing immunity would not be required to protect women from chlamydia disease.
On the other hand if, as suggested by the immunological paradigm, if a small antigenic insult at the site of the oviduct upon re-challenge induces tissue-damaging memory T cell responses, it would be essential for a vaccine to prevent even minimal infection of the oviduct. Thus, sterilizing immunity will be required for a vaccine to be protective. In this instance, chlamydia control programs would have to pay vigorous attention to preventing repeat infection among women with evidence of a strong CD4 Th1 memory response.
A review of published studies reveals possible avenues to the identification of specific cytokine and cellular responses that predict sequelae. Determination of biomarkers of disease will allow control efforts to be intensified for individuals identified at highest risk. We have reviewed in vitro, animal, and human data related to the pathogenesis of chlamydial disease in an effort to better understand how reproductive sequelae result from C. trachomatis infection. We approached our review of the literature with several specific questions in mind.
Which inflammatory/immune responses occur during an initial C. trachomatis infection, and how do they lead to pathology?
The concept of the epithelial cell as an important and early component of the host response to Chlamydia infection was first revealed by Rasmussen et al 14 , who showed that in vitro infection of cervical and colonic epithelial cells with C. trachomatis induced the secretion of an array of proinflammatory cytokines that have chemoattractant and proinflammatory functions. Moreover, in contrast to invasion by other bacteria that induce a rapid but transient proinflammatory cytokine response upon entry 32 , chlamydial invasion alone was not sufficient to elicit a response. Rather, intracellular chlamydial growth was required, and the epithelial cytokine response was sustained throughout the chlamydial developmental cycle. Endocervical epithelial cells released IL-1α after infection, and the induced proinflammatory cytokine cascade could be inhibited by specific anti-IL-1α antibodies 14 . Hence, IL-1α, released on epithelial cell lysis, may act to amplify the inflammatory response by stimulating additional cytokine production. These findings formed the basis for Richard Stephens' "cellular paradigm of chlamydial pathogenesis". Stephens theorized that "the inflammatory processes of chlamydial pathogenesis are elicited by infected host cells and are necessary and sufficient to account for chronic inflammation and the promotion of cellular proliferation, tissue remodeling and scarring --the ultimate cause of disease sequelae" 13 . Since Rasmussen's paper, others have confirmed the elicitation of inflammatory mediators from non-immune host cells infected in vitro with C. trachomatis. Infection of Fallopian tube organ cultures results in epithelial cell release of IL-1 and cellular damage, independent of inflammatory cell influx. The addition of IL-1 receptor antagonist to the cultures completely eliminates tissue destruction induced by infection, indicating a direct role for this cytokine in pathogenesis 33 . In vitro infection of Fallopian tube epithelium also results in the production of tumor necrosis factor (TNF) 34 , and increased expression of adhesion molecules on oviduct endothelial cells 35 . This milieu could easily lead to activation and recruitment of first innate and later, adaptive immune cells to effect resolution of infection. However, subsets of these responses may also induce collateral damage to genital tract tissue.
Proinflammatory chemokines and cytokines have been documented in murine and guinea pig models of genital tract chlamydial infection 4, 36, 37 . The up-regulation of integrins in the murine genital tract is coincident with the onset of infection 2 . Detection of the neutrophil chemokine macrophage inflammatory protein-2 (MIP-2), a chemokine analogous to IL-8 in humans, in genital tract secretions of infected mice coincides with a rapid influx of neutrophils into the lower genital tract. Thus, data to date suggest the inflammatory response to chlamydiae begins and is sustained by actively infected non-immune host epithelial cells. Defining the specific responses that promote tissue damage and differentiating them from those that lead to benign resolution of infection is an important ongoing research goal.
Murine genital tract studies indicate that the intensity of neutrophil influx into the oviduct (pyosalpinx) correlates directly with eventual development of hydrosalpinx 38 . Prolonged infiltration of neutrophils into the oviduct correlates with an increased incidence of severe hydrosalpinx in an immunologically normal mouse strain that exhibits increased disease susceptibility 39, 40 . Data by Morrison et al. 8 revealed that genital chlamydial infection of mice with disrupted β2-microglobulin, I-A, or CD4 genes resulted in tubal ectasia and hydrosalpinx similar to infection of immunologically intact mice. A common feature in all mouse strains tested was the accompaniment of ascending infection of the genital tract with a marked neutrophilic inflammatory response. In Class II −/− mice, a persistent prominent acute-subacute inflammatory response failed to resolve infection but led to development of hydrosalpinx. Although these data do not exclude a role for adaptive immune responses in the development of pathology, they indicate that chronic genital tract tissue damage can occur independently of T cell responses and implicates a role for acute inflammatory cells in its development. Activation of phagocyte oxidase in myeloid cells causes release of superoxide molecules that are damaging to cells and tissues. Mice with a deletion of a key component of phagocyte oxidase (p47phox −/− ) sustain lower rates of hydrosalpinx 41 following chlamydial infection. Other potentially important factors are matrix metalloproteinases (MMPs), which are expressed by neutrophils and monocytes and are involved in the proteolysis and resynthesis of the extracellular matrix. Ramsey et al. have implicated neutrophil production of MMP-9 in the development of scarring and fibrosis of the murine oviduct after chlamydial infection 39 .
Studies in humans also indicate a role for MMPs and neutrophils in production of tissue damage. Fallopian tube epithelial cells infected in vitro with C. trachomatis produce MMP-2, and infected oviduct stromal cells produce MMP-9 42 . The importance of neutrophil activation in the inflammatory process associated with C. trachomatis infection of the female reproductive tract is also revealed in a study of women at risk for PID, where vaginal levels of neutrophil α-defensins (HNP1-3), markers of neutrophil activation, were strongly associated with the presence of endometritis 43 . Absolute numbers of vaginal neutrophils were associated with endometritis only in the presence of elevated defensin levels. Although oculogenital serovars are killed by neutrophils, in human endometrial epithelial cell cultures monitored for more than 1 month after exposure to azithromycin (a chlamydiacidal antibiotic)-loaded neutrophils, residual chlamydial envelopes and MOMP and LPS antigens were detected and continued to stimulate neutrophil chemotaxis 44 . Thus, antigens may persist for some time after the organisms are killed, inducing continued neutrophil inflammation and ongoing release of tissue damaging molecules in the host.
Taken together, these data imply that ascension of chlamydiae from the lower to the upper genital tract, and ultimately infection of oviduct epithelium is a prerequisite for the development of long-term sequelae. Support of this hypothesis comes from the lack of detection of oviduct pathology in mice infected vaginally with human serovars 4 , where infection of the cervix and endometrium occur, but oviduct infection does not 4, 45 . Human serovars elicit oviduct pathology in the mouse when they are inoculated directly under the ovarian bursa 46 . On the other hand, infection of the oviduct does not guarantee disease development. Rank and Sanders documented oviduct infection occurred in 78% of vaginally inoculated guinea pigs, but chronic oviduct pathology was seen in only 12% 9 . Thus, additional host factors must influence the development of disease.
Researchers have begun to determine the cellular receptors involved in C. trachomatisinduced stimulation of cytokine release. Toll like receptors (TLRs) act as pathogen recognition receptors that enable cells to recognize conserved bacterial, viral and fungal structural elements. In vitro, C. trachomatis infection of HEK cells transfected with the adaptor molecule, MyD88, and the pathogen molecular pattern receptors, TLR2 and TLR4/ MD-2, revealed TLR2 was required for IL-8 secretion and the role of TLR4/MD-2 was minimal. This was reproduced with chlamydial infection of immortalized human ectocervical epithelial cells 47 . Activation was dependent on live, replicating bacteria because infection with UV-irradiated bacteria and treatment of infected cells with chloramphenicol (no inclusions), but not ampicillin (jammed in reticulate body [RB] form), abrogated the induction of IL-8 secretion. The response was largely dependent on the MyD88 adaptor molecule. Confocal microscopy experiments revealed that both TLR2 and MyD88 co-localize with the intracellular chlamydial inclusion, suggesting that TLR2 is actively engaged in signaling from this intracellular location.
Examination of the outcomes of genital tract infection in wild-type mice and mice genetically deficient in TLR2 and TLR4 confirmed a dominant role for TLR2 versus TLR4 in the recognition and response to C. muridarum in the genital tract 48 . TLR4-/-mice responded to infection similarly to wild-type controls, and developed similar pathology. Eradication of lower genital tract infection was equivalent in TLR2-/-mice and wild-type mice, even in the early days after infection. However, significantly lower levels of TNF-α and MIP-2 were detected in genital tract secretions of TLR2-/-mice during the first week of infection, and there was a significant reduction in oviduct and mesosalpinx pathology at later time points. Thus, the cytokine response that remained in the absence of TLR2 signaling was sufficient to recruit effector cells to the genital tract, but these data indicate a protective role for TLR2 deficiency in genital tract infection sequelae due to C. trachomatis. Wild-type mice that are infected with plasmid-deficient C. muridarum that fail to signal via TLR2 develop a predominant Th1 response, and they are as resistant to secondary challenge infection as immunologically normal mice primarily infected with wild-type C. muridarum 49 . Thus, although pathology is abrogated, chlamydia-induced signaling that is independent of TLR2 leads to an effective acquired immune response, speaking to the redundancy of the innate immune system. The oviduct bacterial burden induced by infection with the plasmid-deficient strain of C. muridarum, CM3.1, is not different from that induced by infection with wild-type C. muridarum 49 . It is possible that the downstream immune response elicited by infection with this plasmid-deficient chlamydial strain is simply globally muted in intensity, or that the quality of the response is altered and specific mediators of tissue damage are no longer induced. Regardless of mechanism, these data confirm the ability of the host epithelial cell-initiated response to induce downstream immune effectors that eradicate oviduct infection without causing chronic pathology, and prevent pathology upon secondary infection.
Examination of human tissues for the various TLRs has revealed mRNA for TLRs1-9 in uterine epithelium 50 . TLR2 is highly expressed in Fallopian tubes and the cervix 51 ; whereas TLR4 is weakly expressed in Fallopian tubes 51 , and mRNA for TLR4 and its coadaptor MD2 is not detected in human cervical epithelial cells 52 . Thus, by virtue of its relative expression, TLR2 may be a primary pathogen recognition receptor available in the lower genital tract and oviducts to drive the pathology-inducing inflammatory response to chlamydial infection.
There are only a few published studies of the histopathology of C. trachomatis-infected human reproductive tract tissue. Human endocervical biopsies from girls/women with mucopurulent cervicitis due to C. trachomatis revealed a focal loss of surface columnar epithelial cells, intrepithelial neutrophils and glandular intraluminal neutrophils 53 . Dense subepithelial plasma cell infiltrates and well formed periglandular germinal centers were also noted. The underlying tissue architecture was maintained. Lymphocytes and histiocytes were present in the stroma but rarely outnumbered plasma cells. Aggregation of neutrophils around cells positive for C. trachomatis by immunofluorescence implies a prominent role for neutrophils in the response. In a study of women with clinically suspected PID, Kiviat, et al. attempted to determine the relationship of histologic endometrial abnormalities with documented oviduct infection and laparoscopically proven acute salpingitis 1 . The best predictor of salpingitis, without discrimination to organism, was the simultaneous presence of >5 neutrophils per X400 field in endometrial surface epithelium, together with one or more plasma cells per X120 field in the endometrial stroma. Features discriminatory for C. trachomatis infection included higher numbers of plasma cells, and more periglandular lymphoid follicles containing transformed lymphocytes. Infiltration of glandular epithelium by neutrophils was observed in patients with documented endometrial and oviduct infection with C. trachomatis. In addition, germinal center formation in subepithelial tissue was commonly noted. The prominence of both acute and chronic inflammatory cells in infected human female genital tract tissues does not assist in the determination of specific cell types responsible for disease sequelae. The subjects in these studies were recruited from STD clinics, with mean age of 22 years in the endocervical biopsy study and 23 years in the endometrial biopsy study. Thus, it is likely that at least a proportion of patients in both groups had a prior history of C. trachomatis infection.
It is difficult to draw conclusions as to the cause and effect nature of cellular infiltrates noted in a single biopsy from an individual infected for an unknown duration. No studies have documented the histology of infection before and after antibiotic treatment; ethical concerns prevent the performance of sequential analyses of tissue specimens in infected persons. In addition, without documentation of negative serology antecedent to the diagnosis of infection, the primary versus repeated nature of the infection is extremely difficult to delineate.
Germinal center formation generally depends on cooperative interactions of helper T cells and B cells. Helper T cells activated by antigen-presenting dendritic cells express a surface molecule called CD40 ligand and secrete cytokines. CD40 ligand on activated helper T cells then binds to CD40 on B cells and initiates B cell proliferation and differentiation. Within a few days of antigen exposure, a single lymphocyte within a germinal center may give rise to 5000 progeny. Thus, the presence of follicles and germinal centers indicates local stimulation of adaptive immune responses occurs in infected female genital tract tissues. Whether follicles persist after infection has resolved is unknown. One might speculate that this local proliferation of adaptive immune cells would enhance resolution of infection and prevent pathology. However, as discussed below, data from models of repeated infection in guinea pigs and monkeys indicate the association of such lymphocytic responses with pathology.
During repeat infections, which immune responses determine pathology, and how?
A determination of which immune responses associated with repeated infection determine pathology is difficult since histologic studies from humans reveal both acute and chronic inflammatory cell infiltrates 1 . Monkey and guinea pig models of repeated infection reveal the early acute inflammatory response occurs with a similar magnitude in both initial and repeat infections, whereas T cells infiltrate more rapidly and in larger numbers in repeat infections compared to a primary infection 54, 55 . The recurrent inflammatory reaction ultimately culminates in fibrosis and scarring 56 . Primary infection in the mouse model induces such severe oviduct pathology that this model is somewhat impractical for addressing the role of specific cell types in induction of pathology with repeat infection.
Reinfection in the macaque salpingeal pocket model results in a rapid lymphocytic infiltration, resulting in notable epithelial cell destruction and the formation of lymphoid follicles 55 . Tertiary infection of pockets reignites lymphocytic activity with focal areas of epithelium destruction and the formation of extensive fibrosis and lymphoid follicles in the deep stroma 30 . Further data from this model indicate the robust inflammatory response to repeat infection may be mediated by cytotoxic CD8 T cells primed against chlamydia heatshock protein 60 (Chsp60) 57 . Thus, this direct inoculation nonhuman primate model displays immune mediated destruction of genital tract tissue which is enhanced with each repeat infection. Human epidemiologic studies indicate increased risk of disease with repeated infection [58] [59] [60] . However, this may be simply a cumulative process rather than due to enhanced destruction with each repeat infection as seen in this primate model. In addition, it should be noted that these models differ from human infections in that the oviducts are infected directly rather than by ascension from the lower genital tract. During natural infection, the time required for ascension of the bacterium to the oviducts may allow for homing of protective memory T cells leading to a decrease in the infectious inoculum and consequent damaging inflammation at this vulnerable tissue site. In addition, animals are not treated with antibiotics between infections, so one cannot extrapolate these data to humans that sustain repeat infection after treatment of an initial infection.
Primary vaginal infection of guinea pigs with C. caviae (formally known as the guinea pig inclusion conjunctivitis (GPIC) serovar of C. psittaci) leads to an ascending infection that is cleared by about 20 days post infection 9 . Although infection of at least one oviduct can be documented in most animals after a primary infection, less than half develop notable tubal pathology. Both cellular and humoral immune mechanisms generated in a primary infection protected animals from reinfection for up to 30 days, however this immunity waned such that animals were susceptible at day 77 and beyond [61] [62] [63] . Although secondary infections were noted to be markedly abbreviated with a significant reduction in bacterial burden, an increased number of animals developed oviduct dilatation with repeat infection 31 . One potential caveat is that oviduct pathology was evaluated 105-112 days post primary infection in challenged animals, and 75-85 days post primary infection in non-challenged animals. It is possible that increased scarring occurred over time, leading to the detection of an increased frequency of oviduct dilation in the challenged animals. However, definite enhancement of cell mediated inflammation upon re-challenge was observed in a subsequent study in the guinea pig model where flow cytometric analysis revealed that significantly higher levels of T and B cells, but not Mac-1 positive cells were recruited to the oviduct in re-challenged animals, compared to animals infected only once 64 . Interestingly, little to no C. caviae reached the oviduct during repeat infection, suggesting that this organ is exceptionally susceptible to a small antigenic insult once primed through an initial infection, and providing strong evidence for a cell mediated mechanism of pathology in repeat infection. Further development of this model, and the use of guinea pig-specific reagents, may provide a useful surrogate to investigate the possibility that repeat infection leads to an accelerated inflammatory response resulting in enhanced disease.
What is the role of host factors in pathogenesis? Are there reliable markers of pathogenesis or pathology?
Studies have suggested an association between specific host immune responses and susceptibility to Chlamydia infection and/or disease (Table) . In a prospective cohort study of women at high risk for C. trachomatis infection, Cohen, et al. 29 found that, at baseline and after adjustment for age and other potential confounding variables, production of IFN-γ by peripheral-blood mononuclear cells (PBMCs) stimulated with Chsp60 strongly correlated with protection against incident C. trachomatis infection, although there was no information regarding development of sequelae. In a small study in Australian women attending a STD clinic Debattista, et al. 65 found that low PBMC IFN-γ and high IL-10 responses to Chsp60 were markers for increased risk of Chlamydia infection and PID. Among human immunodeficiency virus (HIV)-seropositive women, a CD4 lymphocyte count of <400/mm3 was determined to be an independent risk factor for C. trachomatis PID (OR, 21.7; 95% CI, 1.2-383; P = .036) 58 . These studies support a role for chlamydia-responsive CD4 Th1-IFN-γ-producing cells in protection from disease. Among women with chlamydia-related tubal infertility, T cell responses to Chsp60 were associated with a specific IL-10 promoter polymorphism (IL-10-1082AA) and with specific HLA class II DQ alleles (HLA-DQA1*0102 and HLA-DQB1*0602) 29 . Thus, genetic factors that regulate the induction and activation of Th1 cells may be important in directing a protective host response.
A recent study by Agrawal, et al. examined cervical lymphocyte cytokine responses of 255 C. trachomatis antibody-positive women with or without fertility disorders (infertility and multiple spontaneous abortions) as well as of healthy controls negative for C. trachomatis serum IgM or IgG 66 . Flow cytometric analysis revealed a significant increase in the mean number of CD4+ T-lymphocytes in the cervical mucosa of fertile women as compared to those with fertility disorders and to negative controls. The CD8+ T cell population was found to be only slightly increased in the cervical mucosa during chlamydial infection in both groups. Cervical cells from the women with fertility disorders secreted significantly higher levels of IL-1β, IL-6, IL-8 and IL-10 in response to in vitro stimulation with C. trachomatis EBs; whereas cervical cells from antibody-positive fertile women secreted significantly higher levels of IFN-γ and IL-12. RT-PCR analysis confirmed these results for IFN-γ and IL-12. Gene expression levels for IL-10 and IL-4 were significantly higher in cells obtained from women with fertility disorders. These data suggest human chlamydiaresponsive mucosal lymphocytes skewed towards Th1 predominance protect from chronic sequelae.
In contrast to the above data, a study by Barr, et al. provides genetic support for the role of tissue infiltrating memory T cells in pathogenesis 67 . Although the study is limited by a sample size of only 41 C. trachomatis seropositive patients, the chemokine receptor deletion mutation, CCR5-Δ32, correlated significantly with protection from tubal damage. Chemokine receptor 5 is crucial for T cell activation and function. These same investigators compared the outcome of chlamydial genital infection in wild-type mice and mice genetically deficient for CCR5 and determined that although the mice deficient in CCR5 sustained an infection course of greater intensity and duration, they were protected from infertility when compared to immunologically intact mice 67 . These data reveal the potential double-edged effect of T cell effectors activated in response to chlamydial infection.
Investigations of the CD4 T-cell lineage, Th17, may help to explain these conflicting data. The Th17 response has been implicated in the development of infection-induced immunopathology in other models of infection 68, 69 . Th17 cells produce IL-17 which recruits neutrophils to inflammatory sites and induces neutrophil promoting chemokines. Cytokines that influence Th1 and Th2 lineage commitment, specifically IFNγ and IL-4, inhibit the development of Th17 cells 70, 71 . Furthermore, IL-1, which is released from infected epithelial cells, has been shown to promote Th17 differentiation 72 . In light of the role played by Th17 cells in the activation of neutrophils, and the recognition that the Th17 response is dampened by IFNγ, it is possible that chlamydia-specific Th1 cell production of IFNγ acts to inhibit disease-promoting Th17 responses. Low production of IFNγ would allow for increased Th17 responses and increased disease.
Limited studies conducted in Dutch Caucasian women examining for human genetic functional polymorphisms related to the innate immune molecules, TLR4 73 , the LPS sensing TLR4 co-receptor CD14 74 , IL-1β, and the IL-1 receptor 75 have so far revealed no association of functional polymorphisms in genes for these molecules and tubal infertility. In contrast, wild-type homozygosity for mannose-binding lectin (MBL) allele A has been associated with protection against tubal occlusion in Hungarian Caucasian women 76 . Binding of MBL to sugar groups of the C. trachomatis MOMP blocks attachment of organisms to host cells 77 . Thus, low levels of MBL may lead to an increased infectious burden and/or increased ascension to the oviducts, resulting in increased risk for tubal factor infertility. Examination for functional polymorphisms in genes for TLR2, shown to be essential for induction of oviduct pathology in the mouse model, as well as the TLR2 coreceptors TLR1 and TLR6, using banked specimens from women with and without infertility previously enrolled in the PID evaluation and clinical health study (PEACH) 28 are ongoing (Darville T, Haggerty CL personal communication).
Researchers have attempted to determine factors identifiable using cervical samples that predict upper genital tract pathology. As reported above, vaginal neutrophil defensin levels have been shown to correlate with presence of endometritis in women with subclinical PID 43 . An earlier study revealed a strong correlation between detection of neutrophils in cervical secretions and presence of endometritis as determined by biopsy in girls with clinically symptomatic PID 78 . However, it remains to be determined whether leucorrhea and/or elevated cervical mucus defensin levels predict salpingitis and/or increased risk of chronic tubal damage.
One important question is that of the relationship of anti-chlamydial antibodies and disease risk. Risk factors for C. trachomatis PID established in prospective studies conducted in female sex workers include positive serum antibody to Chsp60 58, 79 , and repeated C. trachomatis infection 58 . Among women with mild to moderate PID, antibody titers to C. trachomatis EB measured in the highest tertile at follow-up, but not to Chsp60, were independently associated with elevated rates of recurrent PID and reduced rates of pregnancy 28 . Although these studies link positive antibody responses to chlamydial proteins to sequelae, they may simply be markers for increased exposure to chlamydiae. Increased exposure could be in the form of repeated or chronic infection. Monkeys inoculated in their oviducts with C. trachomatis and subsequently treated with antibiotics were examined for antibodies to Chsp60. A persistent Chsp60 antibody response was correlated with being culture-or ligase chain reaction-positive in the oviducts post treatment, suggesting antibody positivity is a useful marker of chronic infection 80 . These data indicate that prolonged or repeated exposure to chlamydiae leads to increased risk for disease and increased detection of anti-chlamydial antibodies, rather than implicating antibody formation directly in pathogenesis.
Another possibility is that females that are prone to develop high titers of antibody (Th2) are less likely to develop a protective cell mediated (Th1) immune response. While high antibody responses to Chsp60 have been correlated with increased susceptibility to Chlamydia PID 58, 79 , IFN-γ responses to this highly conserved protein have been correlated with protection among the same group of women 58 . Although logistically very difficult, more correlative longitudinal data on antibody and T cell responses are needed in adolescent and adult women who sustain an initial or repeated infection.
Summary and conclusions
The most conclusive pathogenesis data to date reveal that actively infected non-immune host cells are the driving force in the inflammatory response to chlamydia. In vitro and mouse data indicate infected host epithelial cells not only drive influx of inflammatory cells, but release tissue-damaging molecules directly. Mouse and in vitro data implicate neutrophils and proteinases released from activated neutrophils in tissue pathogenesis, and indicate an important role for chlamydia-induced activation of TLR2 in initiation of these responses. However, continued release of chemokines from infected host cells not only drive recruitment of innate neutrophils and monocytes, but also of adaptive T cells and B cells. The intracellular niche of chlamydia make it logical that T cell responses would be important for successful eradication of infection and multiple studies in mice and humans suggest the CD4 Th1 response to be the principle mechanism of host defense. Thus, a key question that needs to be answered is if anamnestic CD4 Th1 responses induced upon reinfection, with ongoing chronic infection or after vaccination cause disease.
Limited evidence from animal models indicates the adaptive T cell response may promote pathology, especially with ongoing chronic or repeat infection. However, recent vaccine studies in mice indicate that induction of a Th1 immune response to vaccine antigens is essential for the vaccine to protect challenged animals from disease 81, 82 . In addition, human immunoepidemiologic studies have shown that women at high risk of exposure that develop chlamydia-specific CD4 + Th1-IFN-γ-producing cells are protected from incident infection 29 . Since it is unlikely that a vaccine that induces primarily antibody responses will be effective against a pathogen that replicates in a protective vacuole intracellularly, conclusive evidence that induction of Th1 immunity is solely protective is crucial for vaccine development.
Although CD8 T cells have been detected in guinea pig and monkey models of repeat infection in association with oviduct disease, the role of these cells in human disease needs to be defined. In addition, chlamydia-specific Th17 cells should be examined as potential mediators of pathogenesis. These cells activate potentially tissue-damaging neutrophils and their activation has been associated with increased inflammation and disease in other infectious disease models.
The application of multi-color flow cytometric methods to determine specific cell types, cell function, and the kinetics of these responses in genital tract tissues using established animal models should assist in answering these questions. These same techniques can be applied to human specimens such as peripheral blood, endocervical brush and endometrial biopsy samples in conjunction with collection of clinical and epidemiological data. Furthermore, knowledge gained from the use of genetically engineered knock-out mouse models related to pathogen-host cell interactions that stimulate disease-inducing immune responses should be investigated in humans. Elucidation of specific cytokine and cellular responses as predictors of sequelae would allow control efforts to be intensified for individuals identified at highest risk for disease. Approaches include examinations conducted with human cells and tissues ex vivo, and large-scale immunoepidemiologic, immunopathologic, and genetic studies correlated with clinical data regarding infection and disease status. 
